Bayer Trendlines Ag Innovation Fund makes first investment
The Fund establishes a new company to develop novel crop protection products.
The Bayer Trendlines Ag Innovation Fund announced it will establish IBI-Ag, a company involved in the crop protection arena. The company’s goal is to discover and develop a novel, environmentally friendly pest management platform.
Modern agriculture faces difficult challenges: The world’s population is growing and the demand for food, feed and energy is increasing. However, increasing agricultural productivity cannot come at the expense of human and environmental safety. Scientists continually endeavor to develop innovative chemical and biological crop protection solutions that meet both high human and environmental safety standards. This is the ultimate goal of IBI-Ag.
Adrian Percy, Global Head of Research & Development at Bayer Crop Science, remarks: “Our collective knowledge is more powerful than that of any single entity. And while I’m proud of the incredible cutting-edge research that takes place in our Bayer laboratories, I’m just as proud of our efforts to collaborate with others in our constant pursuit of greater agricultural sustainability. I believe that our collaboration with Trendlines to support innovations in agriculture leverages the strengths of both parties and am confident that the outcomes will be of benefit to farmers worldwide.”
“Trendlines’ mission is to create and develop companies to improve the human condition. There is no better way to do that than to find solutions to help feed a hungry world,” says Steve Rhodes, Chairman and CEO of Trendlines. “Investing, supporting, and developing companies like IBI-Ag is at the heart of what we do. Bayer shares our commitment to supporting and developing technologies to help shape the future of farming.”
The Bayer Trendlines Ag Innovation Fund was established in April 2016 as a collaborative partnership between The Trendlines Group and Bayer to invest in agricultural technologies. The partnership agreement includes a US$10 million investment from Bayer, which is managed by Trendlines. Bayer’s decades of experience in agricultural science, innovation and regulatory affairs, alongside Trendlines’ specialization in investing in innovative, early-stage medical and agricultural technologies, form the base of this strong alliance.